Join the Breast Cancer, Metastatic group to help and get support from people like you.
Breast Cancer, Metastatic News
Related terms: Metastatic Breast Cancer
Obtaining Second Opinion Delays Treatment for Breast Cancer, but Not Appreciably
TUESDAY, May 6, 2025 – For patients with newly diagnosed breast cancer, obtaining a second opinion is associated with increased overall time from diagnosis to treatment; however, time to treatment...
AACR: Incidence-Based Mortality Dropping for Young Women With Breast Cancer
TUESDAY, April 29, 2025 – Incidence-based mortality (IBM) declined from 2010 to 2020 among women aged 20 to 49 years diagnosed with breast cancer, according to a study presented at the annual...
Program Matches Breast Cancer Patients To Exercise, Rehab
MONDAY, April 28, 2025 – Breast cancer patients fare better if they continue to exercise during their treatment, and a new program can help women get the activity they need to boost their odds,...
Brain Functional Networks Affected by Neoadjuvant Chemo in Breast Cancer
MONDAY, April 14, 2025 – For patients with breast cancer, the brain functional network shows a shift toward a more randomized pattern after neoadjuvant chemotherapy (NAC), with progression of...
Breast Surgery Can Be Omitted After Neoadjuvant Systemic Therapy in Select Patients
FRIDAY, April 11, 2025 – Omission of breast surgery after neoadjuvant systemic therapy (NST) in select patients with invasive breast cancer may be feasible, according to a study published online...
Study Quantifies Breast Shrinkage After T1 Tumor Lumpectomy
FRIDAY, April 4, 2025 – Patients with T1 tumors undergoing breast-conserving therapy/radiation therapy (BCT/RT) may lose about 20 percent of breast volume at one year, according to a study published...
Many Women Undergo Annual Mammography, Despite Biennial Screening Recommendations
FRIDAY, March 28, 2025 – A high proportion of women seem to undergo mammography screening every year, despite recommendations for biennial screening, according to a research letter published online...
Reported Breast, Colorectal Cancer Screening Higher in 2023 Than 2019
MONDAY, March 17, 2025 – In 2023, reported breast and colorectal cancer screening rebounded from pandemic-related declines, and rates were higher than in 2019, according to a research letter...
Female Breast Cancer Mortality Has Stopped Declining in Certain Age Groups
WEDNESDAY, March 12, 2025 – Breast cancer mortality rates have stopped declining in U.S. women aged 20 to 39 years and in those aged 75 years and older, according to a study published online March 6...
Breast Cancer Incidence Rates Vary by Region in U.S. Women Younger Than 40
THURSDAY, Feb. 27, 2025 – For U.S. women younger than 40 years, breast cancer incidence rates vary by geography, according to a study published online Feb. 12 in Cancer Causes & Control. Rebecca D....
Young Women's Locale Plays Role In Breast Cancer Risk
WEDNESDAY, Feb. 26, 2025 – Where a young American woman lives could play a role in her risk for breast cancer, a new study suggests. In fact, the breast cancer risk associated with a young woman’s l...
Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer
THURSDAY, Feb. 6, 2025 – For patients with high-risk, early-stage estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative primary breast cancer (BC), adding...
FDA Approval Expands Earlier Use of Enhertu for Metastatic Breast Cancer
MONDAY, Feb. 3, 2025 – The U.S. Food and Drug Administration has approved Enhertu (trastuzumab deruxtecan) for the treatment of adult patients with unresectable or metastatic hormone receptor ...
Adjuvant Trastuzumab Emtansine Improves Overall Survival in HER2+ Breast Cancer
THURSDAY, Jan. 16, 2025 – For patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer, adjuvant trastuzumab emtansine (T-DM1) improves overall survival more than...
AI-Supported Double Mammogram Reading Improves Detection Rate
TUESDAY, Jan. 14, 2025 – Artificial intelligence (AI)-supported double-reading mammography is associated with a higher breast cancer detection rate, without affecting the recall rate, compared with...
Further information
Related condition support groups
Related drug support groups
anastrozole, letrozole, Arimidex, Herceptin, Femara, tamoxifen, trastuzumab, Ibrance